Fundz

Neurotrope, Inc. reported raising $24.5 Million in an initial SEC Form D filing, from an offering of $24.5 Million

PRIVATEDec 01, 2016

Amount Raised

$24.5 Million

$24.5 Million sold, per SEC Form D (first sale Dec 1, 2016)

Round Type

Venture

New YorkBiotechnology

Quick answer

Neurotrope, Inc. raised $24.5 Million in a funding round, dated December 1, 2016. Neurotrope, Inc. is based in New York, New York, United States.

How much did Neurotrope, Inc. raise?
Neurotrope, Inc. raised $24.5 Million in a funding round on December 1, 2016.
What does Neurotrope, Inc. do?
Neurotrope Bioscience engages in the development of diagnostic and therapeutic technologies for the treatment of neurodegenerative diseases.
Where is Neurotrope, Inc. based and how big is it?
Neurotrope, Inc. is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Neurotrope, Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at Neurotrope, Inc., and when

A new round usually means Neurotrope, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neurotrope, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neurotrope, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neurotrope, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neurotrope, Inc.

Location

New York, New York, United States

About

Neurotrope Bioscience engages in the development of diagnostic and therapeutic technologies for the treatment of neurodegenerative diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neurotrope, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neurotrope, Inc.'s next move

See what Strategic adds

Neurotrope, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.